Publications by authors named "Gregory A Locke"

Claim this Profile
I
Identification and characterization of TYK2 pseudokinase domain stabilizers that allosterically inhibit TYK2 signaling.
Gregory A Locke, Jodi Muckelbauer, John S Tokarski, Christopher M Barbieri, Stefan Belić

Methods Enzymol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Non-Nucleotide Small-Molecule STING Agonists Chemotype Hybridization.
Emily C Cherney, Liping Zhang, Julian Lo, Tram Huynh, Donna Wei, Gregory A Locke

J Med Chem· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small molecule and macrocyclic pyrazole derived inhibitors of myeloperoxidase (MPO).
Carol H Hu, Meriah W Neissel Valente, O Scott Halpern, Sutjano Jusuf, Javed A Khan, Gregory A Locke

Bioorg Med Chem Lett· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Orally Active Isofuranones as Potent, Selective Inhibitors of Hematopoetic Progenitor Kinase 1.
Andrew P Degnan, Godwin K Kumi, Christopher W Allard, Erika V Araujo, Walter L Johnson, Gregory A Locke

ACS Med Chem Lett· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and structure activity relationships of 7-benzyl triazolopyridines as stable, selective, and reversible inhibitors of myeloperoxidase.
Scott A Shaw, Benjamin P Vokits, Andrew K Dilger, Andrew Viet, Charles G Clark, Gregory A Locke

Bioorg Med Chem· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benzothiazole-based compounds as potent endothelial lipase inhibitors.
Wei Meng, Leonard P Adam, Kamelia Behnia, Lei Zhao, Richard Yang, Gregory A Locke

Bioorg Med Chem Lett· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent Triazolopyridine Myeloperoxidase Inhibitors.
Nicholas R Wurtz, Andrew Viet, Scott A Shaw, Andrew Dilger, Meriah N Valente, Gregory A Locke

ACS Med Chem Lett· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triazolopyrimidines identified as reversible myeloperoxidase inhibitors.
Franck Duclos, Lynn M Abell, David G Harden, Kristen Pike, Kimberly Nowak, Gregory A Locke

Medchemcomm· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential activation of recombinant human acetyl-CoA carboxylases 1 and 2 by citrate.
Gregory A Locke, Dong Cheng, Mark R Witmer, James K Tamura, Tasir Haque

Arch Biochem Biophys· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression, purification, and characterization of human and rat acetyl coenzyme A carboxylase (ACC) isozymes.
Dong Cheng, Ching-Hsuen Chu, Luping Chen, John N Feder, Gabe A Mintier, Gregory A Locke

Protein Expr Purif· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis